JP Stock MarketDetailed Quotes

7096 StemCell Institute

Watchlist
  • 1646
  • +17+1.04%
20min DelayMarket Closed Nov 18 15:30 JST
16.87BMarket Cap54.23P/E (Static)

StemCell Institute Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

StemCell Institute H1 FY2025 Earnings Date

Currency：JPYNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.40B
1.37B
-26.18M
Miss Est.
+15.42%
+13.21%
-3.63%
EPS
--
26.54
--
+70.24%
Analyst Rating
No Data

StemCell Institute Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 820.000M--
--2025/Q3-- / 780.000M--
Nov 12, 20242025/Q2695.000M / 722.000M--
Aug 7, 20242025/Q1678.000M / 700.000M--
May 14, 20242024/Q4597.000M / 686.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 820.000M--
--2025/Q3-- / 780.000M--
Nov 12, 20242025/Q2695.000M / 722.000M--
Aug 7, 20242025/Q1678.000M / 700.000M--
May 14, 20242024/Q4597.000M / 686.000M--

Unlock Free Earnings Estimates

StemCell Institute Earnings Reports

  • StemCell Institute: Confirmation letter

    Nov 14 14:33

  • StemCell Institute: Half Year Report - Term 26 (2024/04/01 - 2025/03/31)

    Nov 14 14:31

  • StemCell Institute: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025

    Nov 12 14:30

  • StemCell Institute: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

    Nov 12 14:30

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data